
Baird Capital Invests in Jumpcode Genomics
Our venture team recently completed an investment in Jumpcode, a genome technology company focused on improving the understanding of human disease.
Learn More
Baird Capital Invests in HSP Group
We recently invested in HSP Group, a tech-enabled business services firm focused on helping companies manage their international operations and expand globally.
Baird Capital Invests in Upfront Healthcare
We're pleased to announce our investment in Upfront, a leading omnichannel communication and patient engagement platform.